Cannabis Law Report

JULY 26, 2021

SciSparc intends to evaluate the efficacy, safety and tolerability of its Proprietary Cannabinoid-Based Treatment- SCI-110. TEL AVIV, Israel , July 26, 2021 /PRNewswire/ — SciSparc Ltd. In addition, SciSparc had established its supply chain infrastructure for the manufacturing and delivering of the SCI-110 drug.

Research and Development 105

Research and Development Supply Chain Pharmaceutical Treatment 105

Cannabis Law Report

JULY 12, 2021

July 5, 2021 – July 9, 2021. CSE: MSET) revealed additional preclinical data showing strong efficacy and improved safety in a head-to-head comparison with psilocybin. PsyIndex Weekly Update. The PsyIndex moved marginally lower last week, giving up some gains from the prior week. Market Performance. Powered by.

Treatment 66

Treatment Decriminalization Pharmaceutical Data 66

Cannabis Law Report

AUGUST 12, 2021

Net loss for the six months ended 30 June 2021 was $30.2 Net loss for the six months ended 30 June 2021 was $30.2 Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021.

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Cannabis Law Report

JUNE 21, 2021

June 14, 2021 – June 18, 2021. OTC: EHVVF) adds Dr. Jeffrey Kamlet, an expert on cardiac safety in ibogaine treatment, as Chief Medical Officer. PsyIndex Weekly Update. The PsyIndex gave up ground last week following the prior week’s robust gains. ATAI Life Sciences N.V. Market Performance. (CSE: CSE: TRIP).

Clinical Trials 66

Clinical Trials Research and Development Therapy Pharmaceutical 66

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. in 2021 reached $2 billion, according to Statistica.) 2 The seeds of C.

CBD 144

CBD Seed-To-Sale Food Access 144

Veriheal

NOVEMBER 10, 2020

The experiment will only last two years long and is set to start with the first prescription in March 2021. The post France Wants to Experiment With Giving Away Free Medical Cannabis in 2021 appeared first on Cannabis Central.

Chronic Pain 90

Chronic Pain Pharmaceutical Patients Epilepsy 90

NORML

JANUARY 19, 2020

Update : HB 1648 is scheduled for a public hearing in the House Criminal Justice and Public Safety Committee on 1/23/20 at 1:30pm. Update : HB 1614 is scheduled for a public hearing in the House Criminal Justice and Public Safety Committee on 1/23/20 at 11am. NH resident? Send a message to your lawmakers in support of depenalization.

Legislation 250

Legislation Decriminalization Access Patients 250

Veriheal

MAY 16, 2022

Researchers working at the University of Arizona College of Medicine in Tucson have refined a method of ketamine use in the treatment of Parkinson’s disease (PD). Specifically, the group focused on ketamine’s ability to relieve the side effects of a common treatment called Levodopa.

Research and Development 19

Research and Development Treatment Clinical Trials Patients 19

Cannabis Law Report

AUGUST 4, 2021

The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021.

Business 81

Business Research and Development Environment Food 81

Veriheal

DECEMBER 4, 2023

At that time, illicit substances were perceived as a significant threat to both workplace productivity and safety. According to 2021 research from the National Institutes of Health (NIH) , 18.7% Do not attempt to self-diagnose or prescribe treatment based on the information provided.

Policy 119

Policy Safety Treatment Business 119

Veriheal

FEBRUARY 8, 2024

The NBA has been relaxing its prohibition against cannabis since 2021 when the league decided to end random drug testing for the substance. First-time offenders who tested positive for the drug were obligated to enter the basketball league’s substance-use treatment and counseling program.

Advocacy 115

Advocacy Chronic Pain Policy Cannabis 115

Cannabis Law Report

JUNE 12, 2021

Authors’ Abstract for Arkell, McCartney & McGregor (2021). Patients using THC-containing products should avoid driving and other safety-sensitive tasks (e.g., operating machinery), particularly during initiation of treatment and in the hours immediately following each dose. Arkell 2021 Med Cannab & GPs.

Patients 81

Patients THC Safety Treatment 81

Cannabis Law Report

JUNE 2, 2021

As of May 2021, a majority of states allow for the medical use of marijuana. During the 2021 legislative session, the Idaho Legislature was presented with House Bill 108 , proposing to legalize medical marijuana. Epidiolex is a Schedule V controlled substance approved for the treatment of seizures. Idaho Code § 37-2701 et seq.

Law 103

Law Marijuana Oil Pharmaceutical 103

MMJ Recs

NOVEMBER 11, 2020

Which countries have been taking steps towards medical marijuana (MMJ) legalization that could potentially be finalized in 2021 or shortly after? This question is being asked by patients all over the world who would see a massive benefit in their quality of life if they could avail of medical marijuana treatment.

Legalization 52

Legalization Decriminalization Marijuana Epilepsy 52

Veriheal

NOVEMBER 28, 2023

The inaccuracy of impairment detection not only puts road safety at risk but also exposes innocent drivers to potential legal consequences. It requires striking a balance between adjusting to societal changes and ensuring public safety. Notably, a 2021 study conducted by Johns Hopkins University raised these concerns.

THC 115

THC Safety Treatment Legalization 115

Cannabis Law Report

DECEMBER 7, 2021

Scientific Reports volume 11 , Article number: 23462 ( 2021 ) Cite this article. Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Metrics details.

Safety 52

Safety Cannabinoids Data Events 52

Cannabis Law Report

JUNE 4, 2021

– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. NEW YORK , June 4, 2021 /PRNewswire/ — AIkido Pharma Inc. Nasdaq: AIKI ) (“AIkido” or the “Company”) today announced that positive Phase 1 testing data was presented at the 2021 ASCO Annual Meeting June 4 , 2021.

Data 100

Data Research and Development Clinical Trials Therapy 100

The Cannigma

MARCH 7, 2022

A recent 2021 review of the literature found that there is simply no substantial evidence to back CBN’s claim to sedation and that more human research is needed. It is exploring the treatment of pain from osteoarthritis with cannabinoid ratios – specifically, CBD + CBN and CBD + THC versus placebo. Common cannabinoids in cannabis.

THC 140

THC Clinical Trials Sleep Cannabinoids 140

Cannabis Law Report

JUNE 12, 2021

Road safety risks associated with medicinal cannabis appear similar or lower than numerous other potentially impairing prescription medications. Available online 6 June 2021. Here we undertake an analysis of this policy issue based on a case study of the introduction of medicinal cannabis in Australia. Conclusion.

Policy 51

Policy Safety Medicine Access 51

Cannabis Law Report

OCTOBER 22, 2021

The “Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” drug pipelines has been added to ResearchAndMarkets.com’s offering. Medical Marijuana – Cannabidiol – Pipeline Insight, 2021” report provides comprehensive insights for about 25+ companies and 50+ pipeline drugs in Medical Marijuana – Cannabidiol pipeline landscape.

Research and Development 52

Research and Development Pharmaceutical Marijuana Chronic Pain 52

Cannabis Law Report

JUNE 21, 2021

In the medical cannabis industry, mostly due to the plant’s long history of prohibition, there is a decided lack of data regarding the use and efficacy of cannabis as a treatment for a wide variety of indications. The most recent one , from June 2021, takes a look at patients using cannabis to relieve pain. RYAH Group Inc.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

JUNE 16, 2021

Patients deserve more options, and to be assured of the safety and efficacy of their treatments; similarly, physicians deserve answers and are a critical partner in the development of this new therapeutic class,” says Erin Prosk , President of Santé. ABOUT SANTÉ CANNABIS.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 29, 2021

In 2021, average home values increase by $470 for every $1 million increase in overall tax revenue from cannabis. . Oregon, for example, donates 40% of its tax revenue to the state’s school fund, accumulating $180,252,103 between 2017 and 2021. Substance abuse education and treatment programs. Public health and safety programs.

Data 116

Data Legalization Education Programs 116

TheAnswerPage

OCTOBER 11, 2021

Has the use of a transdermal gel for regional and systemic delivery of CBD been evaluated for the treatment of epilepsy? A transdermal gel for regional and systemic delivery of CBD (Zynerba Pharmaceuticals) is in clinical development for treatment of epilepsy, developmental and epileptic encephalopathy, fragile-X syndrome, and osteoarthritis.

Epilepsy 40

Epilepsy Topical Treatment Safety 40

Cannabis Law Report

SEPTEMBER 15, 2021

More than 100 people in the US have been hospitalized in 2021 after using Delta-8 THC products, federal health regulators warned Tuesday. National poison control centers received 661 exposure cases of delta-8 THC products between January 2018 and July 31, 2021, 660 of which occurred between January 1, 2021, and July 31, 2021.

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

AUGUST 22, 2021

16, 2021 /CNW/ — PsyBio Therapeutics Corp. The addition of methylated tryptamines with pending patent protection is focused on the potential improvement of treatments for mental health conditions including depression, anxiety and addiction, as well as other psychological and neurologic conditions. .”

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

The Blunt Truth

MARCH 8, 2021

On February 22, 2021, New Jersey Governor Phil Murphy signed A21, the “New Jersey Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act” (NJCREAMMA), which is enabling legislation for the amendment to the New Jersey Constitution making lawful the recreational use of marijuana in the state. Next Steps for Employers.

Recreational 111

Recreational Law Marijuana Safety 111

LifeCannMD

MAY 27, 2025

What really opened my eyes was this study that came out in 2021. times more likely to achieve their treatment goals with medical cannabis. A 2021 study in Frontiers in Pharmacology showed that CBD enhances THC’s therapeutic effects while reducing anxiety and cognitive impairment.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”. Licensing, Agents, and Equity.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

Veriheal

AUGUST 16, 2023

In an unprecedented move that embraces the evolving landscape of sports health and wellness, the National Football League (NFL) has recently made a significant investment in cannabidiol (CBD) research, aiming to explore its potential as a pain treatment alternative for players suffering from concussions.

CBD 98

CBD Research and Development Treatment Policy 98

Canna Law Blog

JANUARY 10, 2020

Per the press release: Newsom intends to combine all three California cannabis agencies into one single Department of Cannabis Control by July 2021. million will be available for youth education, prevention, early intervention, and treatment; environmental protection; and public safety-related activities in 2020 and 2021.

Collective 95

Collective Retail Cultivation Agriculture 95

TheAnswerPage

OCTOBER 21, 2021

According to the European Pain Federation position paper on the appropriate use of cannabis-based medicines, “a testing period of maximum 3 months should be considered both by patients and prescribers [or recommenders], to assess treatment efficacy and safety. At the end of this testing period, long?term New accredited CME/CE courses.

Chronic Pain 45

Chronic Pain Therapy Treatment Safety 45

TheAnswerPage

OCTOBER 6, 2021

According to a JAMA Open Network article published in September 2021, in a “nonrandomized controlled trial, CBD transdermal gel was well tolerated over 6.5 months of treatment, with 60% of patients experiencing a treatment-related adverse event, 96% of which were mild or moderate. JAMA Netw Open. 2021;4(9):e2123930.

Sleep 40

Sleep Treatment Concentrates Safety 40

Cannabis Law Report

AUGUST 18, 2021

As we previously reported , on February 22, 2021, New Jersey Governor Phil Murphy signed three separate cannabis reform bills into law ( NJ A21 , NJ A 1897 , and NJ A5342/NJ S3454 ), formally legalizing the use and possession of recreational marijuana in the Garden State. Here’s a round-up of the most recent developments: New Laws.

Legislation 105

Legislation Legalization Marijuana Recreational 105

Cannabis Law Report

JUNE 25, 2021

DUBLIN–(BUSINESS WIRE)–The “Skin Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030” report has been added to ResearchAndMarkets.com’s offering. billion in 2021 at a compound annual growth rate (CAGR) of 11.8%. The global skin cancer drugs market is expected to grow from $1.44

Research and Development 65

Research and Development Therapy Pharmaceutical Clinical Trials 65

Cannabis Law Report

AUGUST 5, 2021

Psychedelics are quickly emerging as alternative methods of treatment for mental illnesses and neurodegenerative conditions — particularly in countries such as Canada. Although the overarching market is still relatively new, much like the cannabis boom a few years ago the psychedelics space is growing at an unprecedented rate.

Extraction 105

Extraction Clinical Trials Research and Development Pharmaceutical 105

TheAnswerPage

OCTOBER 17, 2021

In September 2021, California Governor G. Newsom signed “Ryan’s Law” – legislation that expands end-of-life treatment options for Californians by requiring that hospitals and certain types of healthcare facilities in the state allow terminally-ill patients to use medical cannabis for treatment and/or pain relief.

Treatment 40

Treatment Patients Compliance Compliance 40